Page last updated: 2024-11-05

wb 4101 and Diabetes Mellitus, Adult-Onset

wb 4101 has been researched along with Diabetes Mellitus, Adult-Onset in 1 studies

N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamine : A benzodioxine that is 2,3-dihydro-1,4-benzodioxine bearing a [(2',6'-dimethoxyphenoxy)ethylamino]methyl group at position 2. An alpha1A-adrenergic selective antagonist.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Artasensi, A1
Angeli, A1
Lammi, C1
Bollati, C1
Gervasoni, S1
Baron, G1
Matucci, R1
Supuran, CT1
Vistoli, G1
Fumagalli, L1

Other Studies

1 other study available for wb 4101 and Diabetes Mellitus, Adult-Onset

ArticleYear
Discovery of a Potent and Highly Selective Dipeptidyl Peptidase IV and Carbonic Anhydrase Inhibitor as "Antidiabesity" Agents Based on Repurposing and Morphing of WB-4101.
    Journal of medicinal chemistry, 2022, 10-27, Volume: 65, Issue:20

    Topics: Adrenergic Agents; Caco-2 Cells; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Diabetes Mellit

2022